Table 1.
The comparison of clinical and genetic features between HOXA10-high and HOXA10-low groups
| HOXA10-low group (n = 72) | HOXA10-high group (n = 73) | p value | |
|---|---|---|---|
| Age (year) | 52.08 ± 17.592 | 56.63 ± 14.730 | 0.094 |
| Gender | 0.739 | ||
| Female | 31 | 34 | |
| Male | 41 | 39 | |
| Race | 0.717 | ||
| White | 50 | 53 | |
| Other races | 22 | 20 | |
| Mutation count | 9.43 ± 5.897 | 9.63 ± 5.116 | 0.826 |
| FAB subtype | < 0.0001 | ||
| M3 | 15 | 0 | |
| non-M3 | 57 | 73 | |
| Risk stratification of cytogenetics | < 0.0001 | ||
| Good | 29 | 1 | |
| Intermediate | 26 | 55 | |
| Poor | 16 | 15 | |
| Risk stratification of molecular mutation | < 0.0001 | ||
| Good | 30 | 1 | |
| Intermediate | 25 | 50 | |
| Poor | 16 | 20 | |
| WBC | 28.693 ± 45.009 | 40.800 ± 36.862 | 0.078 |